Description of participants at baseline. by Jason Shourick (11436869)

Subjects:

Alpha diversity analysis evaluated by diversity measure using Shannon index for genus level according to the type of disease and BMI status. by Lourdes Chero-Sandoval (22683418)

Subjects:

Comparison of anthropometric measurements, body composition and clinical variables among participants with low-grade MI and SLE and according to BMI status of the population. by Lourdes Chero-Sandoval (22683418)

Subjects:

Predicted values of C-reactive protein in patients with low BMI and high BMI, according to the relative abundance of <i>Alistipes shahii</i> patients with SLE (R² = 0.23... by Lourdes Chero-Sandoval (22683418)

Subjects:

The analysis of the microbial structure based on linear discriminant analysis (A) and Random Forest (B), abundance analysis using EdgeR (C) according to the type of inflammatory di... by Lourdes Chero-Sandoval (22683418)

Subjects:

Differences in the C-reactive protein between individuals with different categories of <i>Alistipes</i> within each group IL-6 and different categories of BMI within each group of... by Lourdes Chero-Sandoval (22683418)

Subjects:

Comparison of hematological and inflammatory variables between types of disease (low-grade metabolic inflammation and systemic lupus erythematosus) according to BMI status. by Lourdes Chero-Sandoval (22683418)

Subjects:

Multivariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Seroprevalence of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Descriptive statistics and demographics of study participants, Ukunda and Kisumu sites, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

DENV and CHIKV IgG serology and RT-PCR test results among overall study population and individual study sites Ukunda and Kisumu, Kenya, Dec 2019–Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Univariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Seroconversion of DENV and CHIKV among study participants in Kisumu and Ukunda, Kenya, Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Kaplan Meier survival curves for new CHIKV seropositivity during the 2- year study period from Dec 2019 – Feb 2022. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Kaplan Meier survival curves for new DENV seropositivity during the 2-year study period from Dec 2019 – Feb 2022.. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Multivariate analysis between DENV and CHIKV seropositivity and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Univariate analysis between DENV and CHIKV seroconversion and selected risk factors. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Distribution of DENV and CHIKV seroprevalence by age group of participants in the study. by Bethel Alebel Bayrau (22676588)

Subjects: “…seropositivity among individuals…”

Sociodemographic data and main univariable subgroup analyses. Other ethnicities includes all ethnicities not categorised as black, mixed, south Asian or white. by Alex Gough (16734033)

Subjects:

Variables extracted from database. by Alex Gough (16734033)

Subjects: